NSC 66811

Cat No. 2936

NSC 66811 C23H20N2O [6964-62-1]

Price and Availability

For NSC 66811 pricing & availability please select your country from the drop down menu:
Submit

Chemical Name: 2-Methyl-7-[Phenyl(phenylamino)methyl]-8-quinolinol

Biological Activity

Potent MDM2 inhibitor (Ki = 120 nM) which disrupts MDM2-p53 interaction and activates p53 function. Induces p21, p53 and MDM2 accumulation in human colon cancer cells in vitro.

Technical Data

M.Wt:
340.42
Formula:
C23H20N2O
Solubility:
Soluble to 100 mM in DMSO
Purity:
>97 %
Storage:
Store at +4°C
CAS No:
[6964-62-1]

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.

Certificate of Analysis / MSDS

Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch

References

Lu et al (2006) Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J.Med.Chem. 49 3759. Shangary and Shaomeng (2009) Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Ann.Rev.Pharmacol.Toxicol. 49 223.

If you know of a useful citation for this product please let us know.

Keywords: NSC 66811, MDM2, antagonists, Disrupts, MDM2-p53, interaction, Transcription, Factors, NSC66811

Buy Now / Print Quote

Find multiple products by catalog number


divider line

Print Quote Facility

Order via your purchasing department

Print Quote Facility

It's now even easier to place orders via your purchasing department.

Simply add a product to your cart & click on the "Print Quote" button.

more
divider line

Signal Transduction Guide

Signal Transduction Guide

A collection of more than 600 products for signal transduction research. View PDF today.

request
divider line

Cancer Research Guide

Cancer Research Guide

Highlights over 400 products for cancer research. Request a copy or view PDF today.

request
divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

request
divider line

New Products in this Area

HLI 373

Hdm2 inhibitor; activates p53-dependent transcription

SJ 172550

MDMX inhibitor. Disrupts MDMX-p53 interaction

INH1

Hec1 inhibitor; causes arrest of mitosis

Cyclic Pifithrin-α hydrobromide

p53 inhibitor

Sign-up for new product e-alerts
divider line

Special Offer

25% discount* on selected Tocris products:


*Terms and Conditions

To view more special offers....

submit